Victory Capital Management Inc Organogenesis Holdings Inc. Transaction History

Victory Capital Management Inc

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 05, 2024	SELL	$2.28 - $3.03 $332 - $442	-146 Reduced 1.43%	10,053 $28,000
Q1 2024 May 03, 2024	SELL	$2.61 - $4.49 $1,101 - $1,894	-422 Reduced 3.97%	10,199 $28,000
Q4 2023 Feb 05, 2024	BUY	$1.97 - $4.21 $20,923 - $44,714	10,621 New	10,621 $43,000
Q1 2023 May 02, 2023	SELL	$1.89 - $2.93 $4,830 - $7,489	-2,556 Reduced 8.27%	28,343 $60,000
Q4 2022 Feb 09, 2023	SELL	$2.48 - $3.43 $311,914 - $431,397	-125,772 Reduced 80.28%	30,899 $83,000
Q3 2022 Nov 02, 2022	SELL	$3.14 - $6.43 $15,897 - $32,555	-5,063 Reduced 3.13%	156,671 $508,000
Q2 2022 Aug 01, 2022	SELL	$4.74 - $8.15 $335,909 - $577,566	-70,867 Reduced 30.47%	161,734 $789,000
Q1 2022 May 04, 2022	BUY	$6.47 - $9.57 $25,200 - $37,275	3,895 Added 1.7%	232,601 $1.69 Million
Q4 2021 Feb 07, 2022	BUY	$9.02 - $13.5 $1.59 Million - $2.38 Million	176,616 Added 339.06%	228,706 $2.11 Million
Q3 2021 Nov 02, 2021	BUY	$13.71 - $17.18 $337,046 - $422,353	24,584 Added 89.38%	52,090 $742,000
Q2 2021 Aug 03, 2021	BUY	$14.92 - $23.23 $410,389 - $638,964	27,506 New	27,506 $457,000
Q2 2020 Aug 07, 2020	SELL	$2.86 - $4.61 $9,638 - $15,535	-3,370 Closed	0 $0
Q1 2020 May 04, 2020	BUY	$2.92 - $5.31 $3,936 - $7,157	1,348 Added 66.67%	3,370 $11,000
Q4 2019 Feb 04, 2020	BUY	$4.7 - $8.11 $4,107 - $7,088	874 Added 76.13%	2,022 $9,000
Q3 2019 Nov 12, 2019	BUY	$3.57 - $8.09 $4,098 - $9,287	1,148 New	1,148 $8,000

117

63.2M

25K

23.2K

Ticker ORGO
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 130,888,000
Market Cap $406M
Description
Organogenesis Holdings Inc., a regenerative medicine company develops, manufactures, and commercializes solutions for the advanced wound care, and surgical and sports medicine markets in the United States. The company's advanced wound care products include Affinity, an amniotic membrane wound covering in which viable cells growth factors/cytokin...

Get notified when there are updates to the investment portfolio of Victory Capital Management Inc, based on Form 13F filings with the SEC.

Stay updated on Victory Capital Management Inc with notifications on news.